SSM Health St. Anthony Hospital - Shawnee
1102 W Macarthur, Shawnee, OK · SSM Health · · NPI 1134123193
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj for ext venography CPT 36005 | $601.70 | $1,094.00 | $71.51 – $71.51 | 1 |
| Inj for mammo ductogram CPT 19030 | $504.90 | $918.00 | $115.20 – $115.20 | 1 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.04 – $1.94 | 9 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $503.85 – $1,140.19 | 9 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $5.24 – $5.24 | 1 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $4.12 – $87.05 | 9 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $33.84 – $81.26 | 7 |
| Inj, gadopiclenol, 1 ml HCPCS A9573 | not published | not published | $5.56 – $18.68 | 2 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $52.50 – $84.59 | 2 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $193.20 – $328.89 | 2 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $10.73 – $14.42 | 3 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $120.92 – $235.78 | 9 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,864.68 – $5,586.12 | 9 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $2.06 – $2.65 | 2 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | not published | not published | $1.92 – $1.92 | 1 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $168.00 – $270.68 | 2 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $3.22 – $9.31 | 9 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $66.92 – $223.51 | 8 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $12.22 – $17.90 | 2 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,691,450.00 – $7,198,327.50 | 7 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $3.65 – $7.52 | 3 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $58.34 – $113.77 | 9 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $32.46 – $92.61 | 7 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $54.94 – $118.25 | 9 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | not published | not published | $69.58 – $69.58 | 1 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | not published | not published | $77.54 – $77.54 | 1 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | not published | not published | $82.67 – $82.67 | 1 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | not published | not published | $40.29 – $40.29 | 1 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | not published | not published | $38.98 – $38.98 | 1 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.49 – $2.90 | 9 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $14.32 – $23.08 | 2 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $79.51 – $155.05 | 9 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $3.10 – $4.04 | 3 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $81.24 – $158.42 | 9 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.17 – $0.22 | 2 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $510.65 – $995.77 | 9 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $215.92 – $1,691.55 | 9 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $49.40 – $66.16 | 2 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $2.45 – $2.45 | 1 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $45.45 – $377.53 | 8 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $69.05 – $377.53 | 8 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $13.26 – $25.86 | 9 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $51.22 – $99.88 | 9 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.94 – $3.78 | 9 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.76 – $5.37 | 9 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.60 – $3.11 | 9 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $1.71 – $4.20 | 3 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $88.22 – $172.02 | 8 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $20.33 – $80.12 | 9 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.34 – $2.62 | 9 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.88 – $1.15 | 2 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $22.94 – $44.73 | 9 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $30.23 – $58.01 | 3 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.02 – $0.11 | 3 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $6.84 – $13.33 | 8 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $6.37 – $8.22 | 2 |
| Inj, lidocaine w epinephrine HCPCS J2004 | not published | not published | $0.01 – $0.01 | 1 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $7.86 – $32.95 | 3 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,235,303.98 – $6,308,842.76 | 7 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $336.97 – $657.10 | 9 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $23.39 – $45.62 | 8 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,069.64 – $5,985.79 | 8 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | not published | not published | $197.13 – $197.13 | 1 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $5.29 – $5.29 | 1 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $104.90 – $251.36 | 9 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $803.59 – $803.59 | 1 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $801.48 – $1,562.88 | 8 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $254.89 – $383.38 | 2 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $4.50 – $5.80 | 3 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.59 – $3.47 | 3 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.22 – $4.33 | 8 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $1.98 – $2.57 | 2 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $1.89 – $1.89 | 1 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.38 – $0.56 | 3 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $32.66 – $76.11 | 8 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $258.54 – $504.15 | 9 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $26.48 – $51.63 | 8 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $10.63 – $15.49 | 3 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $8.80 – $11.36 | 3 |
| Inj multihance HCPCS A9577 | not published | not published | $2.26 – $3.02 | 3 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $2.24 – $2.91 | 3 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.38 – $1.20 | 3 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $11.42 – $14.74 | 3 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $684.90 – $1,335.55 | 9 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | not published | not published | $99.39 – $1,307.75 | 8 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.17 – $4.22 | 7 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $94.31 – $183.90 | 8 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $228.36 – $3,869.58 | 8 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $179.08 – $3,869.58 | 8 |
| Inj, nyposi 1 mcg HCPCS Q5148 | not published | not published | $0.95 – $2.02 | 7 |
| Inj ocrelizumab 1mg hya-ocsq HCPCS J2351 | not published | not published | $48.06 – $93.72 | 8 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $1,946.69 – $1,946.69 | 1 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | not published | not published | $51.93 – $69.25 | 3 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $31.94 – $74.91 | 9 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $96.81 – $96.81 | 1 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $404.95 – $789.65 | 9 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $6.50 – $9.29 | 2 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $4.19 – $8.17 | 8 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,680,037.38 – $5,226,072.90 | 7 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $20.99 – $63.96 | 9 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.